Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2002
07/09/2002US6417340 Nanoparticles having oligonucleotides attached thereto and uses therefor
07/09/2002US6417331 Polypeptides
07/09/2002US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries
07/09/2002US6416972 Purified hybrid nucleic acid
07/09/2002US6416953 Hybridization of polynucleotides conjugated with chromo-phores and fluorophores to generate donor-to-donor energy transfer system
07/09/2002US6416952 Photolithographic and other means for manufacturing arrays
07/09/2002US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion
07/09/2002US6416949 Composition comprising first solid support linked to peptide covalently attached via linking group to second solid support linked to oligonucleotide, wherein supports are beads covalently attached by heterobifunctional crosslinking agent
07/09/2002CA2133845C Adrenocorticotrophic hormone receptor and uses
07/04/2002WO2002052266A1 Method of binding nucleic acid to diamond, diamond-mononucleoside conjugate and diamond-nucleic acid conjugate
07/04/2002WO2002051856A2 Method for immobilising probes, in particular for producing biochips
07/04/2002WO2002000677A8 Nucleic acids, proteins, and antibodies
07/04/2002WO2000074687A9 Antisense modulation of b7 protein expression
07/04/2002US20020086989 Photoactivatable nucleic acid derivatives
07/04/2002US20020086985 Fluorescent dye for use in the detection of preferential compounds
07/04/2002US20020086851 Tetrasodium, ammonium, lithium and potassium salts of P1, P4-di(uridine 5')-tetraphosphate; stable, soluble, nontoxic, of high purity and easy to handle during manufacture
07/04/2002US20020086839 Inhibitors of DNA immunostimulatory sequence activity
07/04/2002US20020086823 Nucleic acids, proteins, and antibodies
07/04/2002US20020086822 Nucleic acids, proteins, and antibodies
07/04/2002US20020086821 Nucleic acids, proteins, and antibodies
07/04/2002US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer
07/04/2002US20020086817 Mannan-binding protein or gene; vaccinia virus vectors
07/04/2002US20020086811 Nucleic acids, proteins, and antibodies
07/04/2002US20020086365 Nucleotide sequencs which code polypeptide for use in the treatment of psychological and neurological disorders
07/04/2002US20020086362 Human amine receptor
07/04/2002US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy
07/04/2002US20020086353 Nucleotide sequences coding polypeptides for use in the treatment of cancer, skin, immunological, nervous system, develpomental and cardiovascular disorders
07/04/2002US20020086352 Methods for expressing endostatin protein
07/04/2002US20020086330 Nucleotide sequences coding polypeptide for use in diagnosis, prevention and treatment of preferential urogenital disorders
07/04/2002US20020086307 Generating multicell substrate for use in microarrays; obtain nonporous substrate, expose to surface treatment, incubate with porous membrane, recover microarray
07/04/2002US20020086291 Analyzing structural properties of nucleotide sequences; obtain nucleotide sequences, hydrolyze nucleotide sequences, separate and detect nucleotide sequences
07/04/2002US20020086285 Variant of LAV viruses
07/04/2002US20020085964 Apparatus and methods for the automated synthesis of oligosaccharides
07/04/2002US20020085954 Depositing an inorganic sol-gel permeation layer on a micro-electronic device for molecular biological reactions; can be created with pre-defined porosity, pore size distribution, pore morphology, and surface area.
07/04/2002DE10059144A1 Modulation der Transkription pro-inflammatorischer Genprodukte Modulating the transcription of pro-inflammatory gene products
07/04/2002CA2847458A1 Defects in periaxin associated with myelinopathies
07/03/2002EP1219710A1 Novel polypeptides and genes encoding the same
07/03/2002EP1219709A1 Nucleozymes
07/03/2002EP1218548A2 Typing of human enteroviruses
07/03/2002EP1218542A2 Methods and compositions for linear isothermal amplification of polynucleotide sequences
07/03/2002EP1218398A1 Antisense modulation of pi3 kinase p110 beta expression
07/03/2002EP1218180A1 Multiple fluid sample processor with single well addressability
07/03/2002EP1169329A4 Oligonucleotides having alkylphosphonate linkages and methods for their preparation
07/03/2002EP1133513A4 Multidomain polynucleotide molecular sensors
07/03/2002EP0689610B1 Dna sequencing by mass spectrometry via exonuclease degradation
07/03/2002EP0437576B1 Homologous recombination for universal donor cells and chimeric mammalian hosts
07/03/2002CN1356392A Process for nucleic acid moleculae hybridization and its equipment
07/03/2002CN1356350A Process for continuously extracting corn protein, olgiose, saponin and nucleic acid from corn germs
07/03/2002CN1356339A High-expression gene of liver cancer, protein coded by it and its application
07/03/2002CN1356336A Selectively coating metal to nucleic acid by nano metal particles generated in-situ
07/03/2002CN1356259A Modified nano silicon particles
07/03/2002CN1086940C Dinucleotides useful for treating lung disease
07/02/2002US6414135 Phosphonylation of alkylnucleoside with bis(trimethylsilyl)phosphonite in base presence; concentration; adding methanol solvent; nuclease resistance; hybridization
07/02/2002US6414134 Regulation of bcl-2 gene expression
07/02/2002US6414127 Pyrimidine derivatives for labeled binding partners
07/02/2002US6414112 Peptide nucleic acids having 2,6-diaminopurine nucleobases
07/02/2002US6413939 Inducible phosphofructokinase and the Warburg effect
07/02/2002US6413769 α(1,3) galactosyltransferase negative porcine cells
07/02/2002US6413760 Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
07/02/2002US6413741 Nucleotide sequence; for potassium channel modulators and gene therapy
07/02/2002US6413738 House dust mite allergen, Der f VII, and uses therefor
07/02/2002US6413722 Silylation surface of solid support; activating with crosslinking agent; reacting with amine-containing polymer; attaching target polynucleotide
07/02/2002US6413559 Baked goods
07/02/2002CA2184908C Human osteoclast-derived cathepsin
07/02/2002CA2133203C Hybrid human/porcine factor viii
07/02/2002CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same
07/02/2002CA2030875C Methods and probes for detecting nucleoside transporter and method for producing the probes
06/2002
06/27/2002WO2002050309A2 A bardet-biedl susceptibility gene and uses thereof
06/27/2002WO2002050308A1 Strand displacement detection of target nucleic acid
06/27/2002WO2002050095A1 Fractionation of macro-molecules using asymmetric pulsed field electrophoresis
06/27/2002WO2002020721A3 Vectors derived from south african arbovirus no. 86
06/27/2002WO2002002227A3 Devices and methods for carrying out chemical reactions using photogenerated reagents
06/27/2002WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
06/27/2002WO2000071561A9 Cd4-independent hiv envelope proteins as vaccines and therapeutics
06/27/2002US20020082417 Compound for use in the treatment of vision defects and chronic obstructive pulmonary diseases
06/27/2002US20020082416 Method for obtaining DNA from fish spermatogonium
06/27/2002US20020082397 Novel receptor-type phosphotyrosine phosphatase-kappa
06/27/2002US20020082392 Antibodies to cell-cycle regulatory proteins, and uses related thereto
06/27/2002US20020082227 An ester linkage moieties of the oligonucleotide is replaced with a thioate linkage, such as phosphrothioates, useful as therapies for treating abnormal/undesirable conditions which can arise as a result of complement activation
06/27/2002US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds
06/27/2002US20020081697 Thermostable enzymes having aminotransferase activity, nucleic acids encoding them and methods of making and using them
06/27/2002US20020081619 Separation of preferential nucleotide sequences; obtain sample, incubate with solid support, elute, recover preferential nucleotide sequences
06/27/2002US20020081616 4,7-dichlorofluorescein dyes as molecular probes
06/27/2002US20020081613 Detecting cancer in a tissue sample; obtain tissue sample, screen for preferential marker, presence of marker indicates cancer
06/27/2002US20020081600 Novel human kinase proteins and polynucleotides encoding the same
06/27/2002US20020081591 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids
06/27/2002US20020081589 Gene expression monitoring using universal arrays
06/27/2002US20020081586 Labeling nucleotide sequences; obtain nucleotide sequences, incubate with buffer and label, recover label nucleotide sequences
06/27/2002US20020081582 Making multimers such as DNA or peptides in chemical reactor by solution-based photochemical reactions involving reagents generated in situ by irradiation
06/27/2002US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents
06/27/2002US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide
06/27/2002US20020081236 In situ synthesis of polynucleotides in arrays on a surface; fluid ejection device, which is activated to dispense a small volume of a fluid through the outlet to form uniform coating
06/27/2002DE10064353A1 Oligonucleotide chip, useful for determining gene expression patterns, contains probes selected for specificity with regions of open reading frame
06/27/2002CA2789252A1 Streptococcus pyogenes antigens and corresponding dna fragments
06/26/2002EP1216309A2 Methods for targeting rna molecules
06/26/2002EP1216255A1 Method for nucleic acid isolation and kit
06/26/2002EP0754050B1 Anti gram positive bacterial methods and materials
06/26/2002CN1355852A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection
06/26/2002CN1355843A Vascular adhesion molecules and modulation of their function
06/26/2002CN1355319A Process for separating nucleic acid from biological particles by solid-phase carrier